Impact of weak MGMT promoter methylation on the prognosis of patients with newly diagnosed glioblastoma
{{output}}
Background: In most cases, routine neuropathological analysis can clearly distinguish between methylated and unmethylated MGMT promoters in glioblastoma (GBM). However, some GBMs display weak MGMT promoter methylation. This study... ...
